$AVTX Balance Sheet | Understand Stock

$AVTX

$6.75 -$0.02 (0.3%) Close

$AVTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Accounts receivable, net
Accounts receivable
Other receivables
Inventory, net
Short-term investments
Prepaid expenses and other current assets
Restricted cash, current portion
Total current assets

Long-term investments
Property and equipment, net
Other long-term asset
Intangible assets, net
Goodwill
Restricted cash, net of current portion
Total assets

Liabilities, mezzanine equity and stockholders’ equity
Current liabilities:
Accounts payable
Deferred revenue
Accrued expenses and other current liabilities
Income taxes payable
Current liabilities of discontinued operations
Notes payable, current
Warrant liability
Contingent consideration
Derivative liability, current
Total current liabilities

Notes payable
Notes payable, non-current
Royalty obligation
Deferred tax liability, net
Derivative liability, non-current
Other long-term liabilities
Total liabilities
Temporary equity, values issued
Series D Preferred Stock
Series E Preferred Stock
Series C preferred stock
Total temporary equity, values issued
Stockholders’ equity:
Common stock—$0.001 par value; 200,000,000 shares authorized at June 30, 2026 and December 31, 2025; 52,900,692 and 18,512,757 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Series C Preferred Stock—$0.001 par value; 4,085 and 34,326 shares of Series C Preferred Stock authorized at June 30, 2026 and December 31, 2025, respectively; 4,085 and 18,792 shares of Series C Preferred Stock issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Series C preferred stock
Series C-1 preferred Stock
Total series C Preferred Stock—$0.001 par value; 4,085 and 34,326 shares of Series C Preferred Stock authorized at June 30, 2026 and December 31, 2025, respectively; 4,085 and 18,792 shares of Series C Preferred Stock issued and outstanding at June 30, 2026 and December 31, 2025, respectively

Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total stockholders’ equity
Total liabilities, mezzanine equity and stockholders’ equity

Comments